These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Inflammatory markers in adults with Prader-Willi syndrome before and during 12 months growth hormone treatment. Höybye C. Horm Res; 2006 Dec; 66(1):27-32. PubMed ID: 16685133 [Abstract] [Full Text] [Related]
13. Linear growth response to exogenous growth hormone in Prader-Willi syndrome. Lee PD, Wilson DM, Rountree L, Hintz RL, Rosenfeld RG. Am J Med Genet; 1987 Dec; 28(4):865-71. PubMed ID: 3688024 [Abstract] [Full Text] [Related]
15. Impairment of GH responsiveness to combined GH-releasing hormone and arginine administration in adult patients with Prader-Willi syndrome. Grugni G, Marzullo P, Ragusa L, Sartorio A, Trifirò G, Liuzzi A, Crinò A, Genetic Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology. Clin Endocrinol (Oxf); 2006 Oct; 65(4):492-9. PubMed ID: 16984242 [Abstract] [Full Text] [Related]
17. Propofol and fentanyl infusions in dogs of various breeds undergoing surgery. Andreoni V, Lynne Hughes JM. Vet Anaesth Analg; 2009 Nov; 36(6):523-31. PubMed ID: 19845923 [Abstract] [Full Text] [Related]